From sales of medicines to impact on peoples’ lives, the Medicines Patent Pool’s work is a game-changer in the access to treatments space.

MPP in Numbers


patent holders with MPP signed agreements


generic manufacturers and product developers have sublicences from MPP


countries have benefitted from access to MPP-licensed products


ongoing pharmaceutical development projects


Billion dollars saved by the international community, from January 2012 to December 2019


Billion doses of treatment supplied to date


Million patient-years of treatment through MPP’s generic partners, from January 2012 to December 2019

KPMG calculated savings of USD1.44 billion and supply of 31.4 million patient-years of treatments through MPP’s generic partners from January 2012 to December 2019. Read the KPMG report.

Impact analysis, highlighting MPP’s sublicensees’ progress on treatments development, are available here.

Go to Our Stories to discover MPP’s impact stories

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders

This website uses cookies to ensure you get the best experience on our website. Learn More